Literature DB >> 30217658

Molecular diversity of Coxsackievirus A10 circulating in the southern and northern region of India [2009-17].

Ashok Munivenkatappa1, Pragya D Yadav2, Dimpal A Nyayanit2, Triparna D Majumdar2, Lucky Sangal3, Shilpi Jain2, Daimond P Sinha1, Anish Shrivastava2, Devendra T Mourya4.   

Abstract

Non-Polio EnteroViruses (NPEV) are one of the known causative agents of Acute Flaccid Paralysis (AFP). In the present study, we identified, sequenced and characterized the complete genome of sixty-five Coxsackievirus-A10, an NPEV. These were isolated from stool specimens of AFP cases from Bihar, Karnataka, Kerala, and Uttar Pradesh (UP) states of India. Evolutionary analysis of complete genome (7420 nucleotides) and VP1 gene (894 nucleotides) demonstrates that there are four different intra-typic strains circulating in India which were dissimilar to Chinese strains. First intratypic strain circulating in UP, Bihar, and Karnataka; second in UP and Karnataka; third in UP and Bihar and; fourth was restricted only to Kerala state. The divergence of Kerala strain with respect to all other circulating strain of UP, Bihar and Karnataka states in India is 24%, 24.9%, and 24.4% respectively. Recombinations were observed between few of these strains which might be one of the factors of the observed intra-typic diversity. ARTICLE SUMMARY LINE: We report the identification, characterization and phylogenetic analysis of sixty-five Non-Polio Enterovirus (NPEV) isolates, performed during the year 2009-17, causing acute flaccid paralysis in pediatric cases with their divergences and recombinations from four states of India.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coxsackievirus A10; Next-generation sequencing; Non-polio Enteroviruses; Phylogenetics; VP1 gene

Mesh:

Year:  2018        PMID: 30217658     DOI: 10.1016/j.meegid.2018.09.004

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  5 in total

1.  Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10.

Authors:  Kelei Li; Fangyu Dong; Bopei Cui; Lisha Cui; Pei Liu; Chao Ma; Haifa Zheng; Xing Wu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2019-12-18       Impact factor: 3.452

Review 2.  Emerging/re-emerging viral diseases & new viruses on the Indian horizon.

Authors:  Devendra T Mourya; Pragya D Yadav; P T Ullas; Sumit D Bhardwaj; Rima R Sahay; Mandeep S Chadha; Anita M Shete; Santosh Jadhav; Nivedita Gupta; Raman R Gangakhedkar; Pradeep Khasnobis; Sujeet K Singh
Journal:  Indian J Med Res       Date:  2019-04       Impact factor: 2.375

3.  Genomic surveillance of coxsackievirus A10 reveals genetic features and recent appearance of genogroup D in Shanghai, China, 2016-2020.

Authors:  Jiayu Wang; Jiajing Liu; Fanghao Fang; Jiajin Wu; Tianjiao Ji; Yuying Yang; Ling Liu; Chongshan Li; Wanju Zhang; Xi Zhang; Zheng Teng
Journal:  Virol Sin       Date:  2022-01-24       Impact factor: 6.947

4.  Construction and characterization of an infectious cDNA clone of coxsackievirus A 10.

Authors:  Qiliang Liu; Hanliang Dan; Xiaoping Zhao; Huoying Chen; Yongbei Chen; Ning Zhang; Zhijing Mo; Hongbo Liu
Journal:  Virol J       Date:  2019-08-06       Impact factor: 4.099

5.  Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China.

Authors:  Jia Xie; Xiao-Han Yang; Si-Qi Hu; Wen-Li Zhan; Chang-Bin Zhang; Hong Liu; Hong-Yu Zhao; Hui-Ying Chai; Ke-Yi Chen; Qian-Yi Du; Pan Liu; Ai-Hua Yin; Ming-Yong Luo
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.